Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.

导出 OA

翻译打印收藏纠错

第一作者： Kyle,Vaccaro

第一单位： Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.

作者： Kyle,Vaccaro ^[1] ; Juliet,Allen ^[1] ; Troy W,Whitfield ^[1] ; Asaf,Maoz ^[2] ; Sarah,Reeves ^[3] ; José,Velarde ^[1] ; Dian,Yang ^[1] ; Anna,Meglan ^[1] ; Juliano,Ribeiro ^[1] ; Jasmine,Blandin ^[1] ; Nicole,Phan ^[3] ; George W,Bell ^[1] ; Aaron N,Hata ^[4] ; Kipp,Weiskopf ^[5]

作者单位： Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. ^[1] Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.;Dana-Farber Cancer Institute, Boston, Massachusetts, USA. ^[2] Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. ^[3] Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.;Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. ^[4] Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.;Dana-Farber Cancer Institute, Boston, Massachusetts, USA.;Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. ^[5]

关键词 Cancer immunotherapy Lung cancer Macrophages Oncology Therapeutics